(2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid

C48H76N8O13 — CID 166003922

IUPAC(2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)CC(N(C)C)C2O)[C@](C)(OC)C[C@@H](C)CN[C@H](CCN[C@H](CC(=O)O)C(=O)O)[C@H]2N(CCCCn3cc(-c4cccc(N)c4)nn3)C(=O)O[C@]12C
InChIInChI=1S/C48H76N8O13/c1-11-37-48(7)41(56(46(64)69-48)20-13-12-19-55-26-35(52-53-55)31-15-14-16-32(49)22-31)33(17-18-50-34(43(61)62)23-38(57)58)51-25-27(2)24-47(6,65-10)42(29(4)39(59)30(5)44(63)67-37)68-45-40(60)36(54(8)9)21-28(3)66-45/h14-16,22,26-30,33-34,36-37,40-42,45,50-51,60H,11-13,17-21,23-25,49H2,1-10H3,(H,57,58)(H,61,62)/t27-,28-,29+,30-,33-,34-,36?,37-,40?,41-,42-,45+,47-,48-/m1/s1
InChIKeyKGIOIOAWIOYWQI-XGZKQXSRSA-N
MW973.18 g/mol
LogP3.17
Rot. Bonds18

About (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid

(2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid (PubChem CID 166003922) has the molecular formula C48H76N8O13 and a molecular weight of 973.18 g/mol. Its IUPAC name is (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid.

Molecular Properties

Compound Name(2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid
PubChem CID166003922
Molecular FormulaC48H76N8O13
Molecular Weight973.18 g/mol
Exact Mass972.55
IUPAC Name(2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid
SMILESCC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)CC(N(C)C)C2O)[C@](C)(OC)C[C@@H](C)CN[C@H](CCN[C@H](CC(=O)O)C(=O)O)[C@H]2N(CCCCn3cc(-c4cccc(N)c4)nn3)C(=O)O[C@]12C
InChIInChI=1S/C48H76N8O13/c1-11-37-48(7)41(56(46(64)69-48)20-13-12-19-55-26-35(52-53-55)31-15-14-16-32(49)22-31)33(17-18-50-34(43(61)62)23-38(57)58)51-25-27(2)24-47(6,65-10)42(29(4)39(59)30(5)44(63)67-37)68-45-40(60)36(54(8)9)21-28(3)66-45/h14-16,22,26-30,33-34,36-37,40-42,45,50-51,60H,11-13,17-21,23-25,49H2,1-10H3,(H,57,58)(H,61,62)/t27-,28-,29+,30-,33-,34-,36?,37-,40?,41-,42-,45+,47-,48-/m1/s1
InChIKeyKGIOIOAWIOYWQI-XGZKQXSRSA-N
XLogP3.17
TPSA279.46 Ų
H-Bond Donors6
H-Bond Acceptors18
Rotatable Bonds18
Heavy Atoms69
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500973.18
LogP ≤ 53.17
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid?
The IUPAC name of (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid (CID 166003922) is (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid.
What is the SMILES notation for (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid?
The canonical SMILES for (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid is CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)CC(N(C)C)C2O)[C@](C)(OC)C[C@@H](C)CN[C@H](CCN[C@H](CC(=O)O)C(=O)O)[C@H]2N(CCCCn3cc(-c4cccc(N)c4)nn3)C(=O)O[C@]12C.
What is the InChIKey of (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid?
The InChIKey is KGIOIOAWIOYWQI-XGZKQXSRSA-N. The full InChI is InChI=1S/C48H76N8O13/c1-11-37-48(7)41(56(46(64)69-48)20-13-12-19-55-26-35(52-53-55)31-15-14-16-32(49)22-31)33(17-18-50-34(43(61)62)23-38(57)58)51-25-27(2)24-47(6,65-10)42(29(4)39(59)30(5)44(63)67-37)68-45-40(60)36(54(8)9)21-28(3)66-45/h14-16,22,26-30,33-34,36-37,40-42,45,50-51,60H,11-13,17-21,23-25,49H2,1-10H3,(H,57,58)(H,61,62)/t27-,28-,29+,30-,33-,34-,36?,37-,40?,41-,42-,45+,47-,48-/m1/s1.
What are the key properties of (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid?
(2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid has a molecular weight of 973.18 g/mol, XLogP of 3.17, 18 rotatable bonds, 6 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[2-[(1S,2R,5R,7R,8R,9R,11R,14R,15R)-16-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11-pentamethyl-4,6,17-trioxo-3,18-dioxa-13,16-diazabicyclo[13.3.0]octadecan-14-yl]ethylamino]butanedioic acid is sourced from PubChem (CID 166003922), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).